MRK
$58.96
Merck &
$.44
.75%
MRK
Earnings Whisper ®
N/A
3rd Quarter September 2015
Consensus:  $0.90
Revenue:  $10.13 Bil
Tuesday
Oct 27
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Guidance announcement made Tuesday, July 28, 2015

What do you expect when MRK reports earnings?
Beat
Meet
Miss

Where is MRK's stock price going from here?
Up
Flat
Down
Stock chart of MRK
Analysts
Summary of analysts' recommendations for MRK
Score
Grade
Pivots
Resistance
$59.92
$59.63
$59.29

$59.00

Support
$58.66
$58.37
$58.03
Tweet
Growth
Description
Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service.
Peers
Regeneron PharmaceuticalsVertex PharmaceuticalsCelgeneJohnson & JohnsonBristol-Myers SquibbBioMarin PharmaceuticalPfizerEndo International plcEli LillyImpax Laboratories